20 Sep GenTel BioSurfaces launches new assay platform
Madison, Wis. – GenTel BioSurfaces, Inc. has launched PATHT HTS, a new platform for high-throughput quantitative immunoassays. PATH HTS was introduced last week at the microarray industry’s annual conference, Chips To Hits in Boston.
“Our customers have been very pleased with the performance of PATH protein microarray slides,” said Robert Negm, vice president of business development for GenTel BioSurfaces. “PATH HTS was designed to meet the pharmaceutical industry’s demand for an automated, high-throughput platform to process more samples, faster,” PATH HTS uses GenTel’s proprietary ultra-thin nitrocellulose technology, the basis of its product line introduced in 2004.
The PATH HTS system includes accessories to enable use with existing microarray instrumentation, including microarray spotters and scanners.